您好，欢迎来到半岛电竞官方网址 ！ [ 登录] [ 免费注册]
半岛电竞官方网址
发布求购
位置： 首页> 半岛bd体育手机客户端 库> URAT1 inhibitor 2
立即咨询
咨询类型：
*姓名：
*电话：
*单位：
Email：
*留言内容：
请详细说明您的需求。
*验证码：
URAT1 inhibitor 2
本半岛bd体育手机客户端 不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
URAT1 inhibitor 2图片
包装与价格：
包装 价格(元)
100mg 电议
250mg 电议
500mg 电议

半岛bd体育手机客户端 介绍
URAT1 inhibitor 2 是一种口服有效的 URAT1和 CYP isozyme抑制剂，对 URAT1 介导的 14C-UA 吸收、CYP1A2、CYP2C9 的 IC50分别为 1.36 μM、16.97 μM、5.22 μM。URAT1 inhibitor 2 在高尿酸血症和痛风的研究中是一个有前途的候选药物。
生物活性

URAT1 inhibitor2 is an orally active and potentURAT1andCYP isozymeinhibitor, withIC50values of 1.36 μM, 16.97 μM, 5.22 μM for URAT1-mediated14C-UA uptake, CYP1A2 and CYP2C9, respectively.URAT1 inhibitor2 is a promising drug candidate in the study of hyperuricemia and gout[1].
IC50& Target

IC50: 1.36 μM (URAT1-mediated14C-UA uptake), 16.97 μM (CYP1A2), 5.22 μM (CYP2C9), >20 μM (CYP2C19), >20 μM (CYP2D6), and >20 μM (CYP3A4M)[1].
体外研究
(In Vitro)

URAT1 inhibitor 2 (compound 23) (0-50 μM, 3-20 min) inhibits URAT1-mediated14C-UA uptake (IC50= 1.36 μM) and CYP cells activity[1].

Cell Viability Assay

Cell Line: Human URAT1, CYP cells[1]
Concentration: 0, 0.05, 0.15, 0.5, 1.5, 5.0, 15, and 50 μM
Incubation Time: 3-20 min
Result: Inhibited URAT1-mediated 14C-UA uptake and CYP cells activity.
体内研究
(In Vivo)

URAT1 inhibitor 2 (Intravenous at 2 mg/kg or orally at 10 mg/kg) has excellent pharmacokinetic properties with the oral bioavailability of 59.3%[1].
URAT1 inhibitor 2 (4, 2, 1, 0.5, and 0.25 mg/kg; Orally) shows orally active and outstanding SUA-lowering activity with a dose-dependent manner in acute hyperuricemia mice[1].
URAT1 inhibitor 2 (1000 mg/kg, intragastric administration, once) shows favorable safety profiles and no obvious acute toxicity[1].
Pharmacokinetic Parameters of URAT1 inhibitor 2 in male Sprague-Dawley rats[1].

parameter unit p.o. i.v.
compoundmax(h) 23 23
AUC (0-t) ng/mL·h 48754.6 16344.8
AUC (0-∞) ng/mL·h 48781.5 16448.8
MRT (0-∞) h 3.3 1.0
t1/2 h 2.2 1.8
Tmax h 0.3
Cmax ng/mL 19185.0
CL mL/min/kg 2.2
F % 59.3

Animal Model: Male Sprague-Dawley rats (n=10)[1]
Dosage: 2 mg/kg (intravenous) or 10 mg/kg (oral administration)
Administration: Intravenous or oral administration
Result: Achieved excellent pharmacokinetic properties with the oral bioavailability of 59.3%.
Animal Model: Acute hyperuricemia mice[1]
Dosage: 4, 2, 1, 0.5, and 0.25 mg/kg
Administration: Orally, once
Result: Showed outstanding SUA-lowering activity.
Animal Model: Kunming mice[1]
Dosage: 1000 mg/kg
Administration: Itragastric administration, once
Result: Showed favorable safety profiles and no obvious acute toxicity.
分子量

456.36
Formula

C21H18BrN3O2S
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
Baidu
map